HER2-Negative Breast Cancer Active Not Recruiting Phase 1 Trials for Alpelisib (DB12015)

IndicationStatusPhase
DBCOND0072181 (HER2-Negative Breast Cancer)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01791478BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast CancerTreatment